Cancer gene therapy

被引:14
作者
Douglas, JT
机构
[1] Univ Alabama Birmingham, Div Human Gene Therapy, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Surg, Gene Therapy Ctr, Birmingham, AL 35294 USA
关键词
cancer; gene therapy; vector; ENZYME PRODRUG THERAPY; INHIBITS TUMOR-GROWTH; DOMINANT-NEGATIVE MUTANTS; CYTOSINE DEAMINASE GENE; THYMIDINE KINASE GENE; DOUBLE SUICIDE GENE; HUMAN BREAST-CANCER; WILD-TYPE P53; IN-VIVO; OVARIAN-CANCER;
D O I
10.1177/153303460300200107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer gene therapy is the transfer of genetic material to the cells of an individual with the goal of eradicating cancer cells, both in the primary tumor and metastases. Cancer gene therapy strategies exploit our expanding knowledge of the genetic basis of cancer, thereby allowing rationally targeted interventions at the molecular level. The successful implementation of cancer gene therapy in the clinic awaits the development of vectors capable of specific and efficient gene delivery to cancer cells. The first clinical applications of cancer gene therapy are likely to be in combination with conventional therapies, such as radiotherapy and immunotherapy.
引用
收藏
页码:51 / 63
页数:13
相关论文
共 118 条
[21]   INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS [J].
CULVER, KW ;
RAM, Z ;
WALLBRIDGE, S ;
ISHII, H ;
OLDFIELD, EH ;
BLAESE, RM .
SCIENCE, 1992, 256 (5063) :1550-1552
[22]  
CURIEL DT, 2002, VECTOR TARGETING THE, P728
[23]   THE P53 TUMOR-SUPPRESSOR GENE INHIBITS ANGIOGENESIS BY STIMULATING THE PRODUCTION OF THROMBOSPONDIN [J].
DAMERON, KM ;
VOLPERT, OV ;
TAINSKY, MA ;
BOUCK, N .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 :483-489
[24]  
Danks MK, 1998, CANCER RES, V58, P20
[25]  
Davidoff AM, 2002, CANCER RES, V62, P3077
[26]   BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase [J].
de Fabritiis, P ;
Petti, MC ;
Montefusco, E ;
De Propris, MS ;
Sala, R ;
Bellucci, R ;
Mancini, M ;
Lisci, A ;
Bonetto, F ;
Geiser, T ;
Calabretta, B ;
Mandelli, F .
BLOOD, 1998, 91 (09) :3156-3162
[27]   TARGETED ERADICATION OF OVARIAN-CANCER MEDIATED BY INTRACELLULAR EXPRESSION OF ANTI-ERBB-2 SINGLE-CHAIN ANTIBODY [J].
DESHANE, J ;
CABRERA, G ;
GRIM, JE ;
SIEGAL, GP ;
PIKE, J ;
ALVAREZ, RD ;
CURIEL, DT .
GYNECOLOGIC ONCOLOGY, 1995, 59 (01) :8-14
[28]  
DESHANE J, 1994, GENE THER, V1, P332
[29]  
Dilber MS, 1997, CANCER RES, V57, P1523
[30]   Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumors [J].
Djeha, AH ;
Thomson, TA ;
Leung, H ;
Searle, PF ;
Young, LS ;
Kerr, DJ ;
Harris, PA ;
Mountain, A ;
Wrighton, CJ .
MOLECULAR THERAPY, 2001, 3 (02) :233-240